http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109847039-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8562812eb311ed2e9a12dda0325dcace |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2019-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f477447e63fd0a07fd6d3ec9cde86929 |
| publicationDate | 2019-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109847039-A |
| titleOfInvention | A kind of traditional Chinese medicine composition for treating breast cancer and use thereof |
| abstract | The invention discloses a traditional Chinese medicine composition for treating breast cancer, which is prepared from the following traditional Chinese medicine raw materials in parts by weight: 15-25 parts of Astragalus, 15-25 parts of Kaijian, 15-25 parts of Hedyotis diffusa, and 10-25 parts of Poria cocos 20 copies, 15-20 copies of Sanleng, 15-20 copies of loofah, 15-20 copies of Fritillaria, 15-20 copies of leeches, 10-20 copies of turmeric, 15-20 copies of Prunella vulgaris, 15-20 copies of Curcuma , 15-20 parts of red rattan, 10-20 parts of kelp, 15-20 parts of elixir, 10-20 parts of dandelion, 10-25 parts of saponin, and 3-6 parts of Bupleurum. The traditional Chinese medicine composition of the invention can promote the apoptosis of tumor cells in breast cancer mice, and has an inhibitory effect on breast cancer; the traditional Chinese medicine composition can inhibit tumor proliferation by up-regulating the expression of caspase-3. |
| priorityDate | 2019-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 88.